Asymmetric Hypertrophic Cardiomyopathy in Athletes: Always a Higher Risk for Sudden Death?

Authors

  • Rafael Thiesen Magliari Hospital Santa Paula – São Paulo (SP), Brazil; Hospital Moriah – São Paulo (SP), Brazil and; Centro de Arritmias e Eletrofisiologia Cardíaca – São Paulo (SP), Brazil.
  • Cecília Bitaraes Hospital Santa Paula – São Paulo (SP), Brazil; Hospital Moriah – São Paulo (SP), Brazil and; Centro de Arritmias e Eletrofisiologia Cardíaca – São Paulo (SP), Brazil.
  • Rodrigo Caligaris Cagi Hospital Santa Paula – São Paulo (SP), Brazil; Hospital Moriah – São Paulo (SP), Brazil and; Centro de Arritmias e Eletrofisiologia Cardíaca – São Paulo (SP), Brazil.
  • Alfredo Augusto Eyer Rodrigues Universidade Federal de São Paulo – São Paulo (SP), Brazil and Grupo DASA – São Paulo (SP), Brazil.
  • Cristiano de Oliveira Dietrich Hospital Santa Paula – São Paulo (SP), Brazil; Hospital Moriah – São Paulo (SP), Brazil and; Centro de Arritmias e Eletrofisiologia Cardíaca – São Paulo (SP), Brazil. https://orcid.org/0000-0002-7373-9119

Keywords:

Sudden death, Athlete heart, Hypertrophic cardiomyopathy

Abstract

Hypertrophic cardiomyopathy (HCM) may be associated with considerable mortality in athletes. However, differentiating myocardial hypertrophy as a physiological adaptation of the heart to exercise can be a clinical challenge. In this context, nuclear magnetic resonance imaging has been shown to be a essential exam for diagnostic elucidation. The case report aimed to depict a young athlete with syncope and an initial investigation suggestive of HCM, which was excluded after deconditioning and serial MRI.

 

Downloads

Download data is not yet available.

References

- Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-1092.

- O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anstasakis A, Rapezzi C, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J 2014;35:2010–2020.

- Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995;92:785-789.

- Steriotis AK, Sharma S. Risk Stratification in Hypertrophic Cardiomyopathy. Eur Cardiol 2015;10:31-36.

- Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy 2004;44:2125-2132.

- Maron BJ. Sudden Death in Young Athletes. N Engl J Med 2003;349:1064-1075.

- Gati S, Sharma S, Pennell D. The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Highly Trained Athletes. JACC Cardiovasc Imaging 2018;11:247-259.

- Brosnan MJ, Rakhit D. Differentiating Athlete’s Heart From Cardiomyopathies – The Left Side. Heart Lung Circ 2018;27:1052-1062.

Downloads

Published

2020-11-06

How to Cite

Magliari, R. T. ., Bitaraes, C. ., Cagi, R. C. ., Rodrigues, A. A. E., & Dietrich, C. de O. (2020). Asymmetric Hypertrophic Cardiomyopathy in Athletes: Always a Higher Risk for Sudden Death?. JOURNAL OF CARDIAC ARRHYTHMIAS, 33(3), 156–160. Retrieved from https://jca.org.br/jca/article/view/3365

Issue

Vol. 33 No. 3 (2020)

Section

Clinical Arrythmia

Categories